Clinical Trial Update: Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on gemcitabine plus supportive care for locally advanced or metastatic non-small cell lung cancer, covering Phase 2 and Phase 3 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Lung Cancer | Phase 2, Phase 3 | Status: UNKNOWN